A total 500 endometrial cancer cases were tested with IHC and MSI (300 recruited prospectively, 200 identified retrospectively having been consented for research), with MLH1 methylation testing and germline next generation sequencing (NGS) being conducted where indicated. This evidence concerns the gene MLH1 and endometrial cancer.